Literature DB >> 28314679

An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Russell W Brown1, Seth L Kirby2, Adam R Denton2, John M Dose3, Elizabeth D Cummins2, Wesley Drew Gill4, Katherine C Burgess4.   

Abstract

This study analyzed the associative properties of nicotine in a conditioned place preference (CPP) paradigm in adolescent rats neonatally treated with quinpirole (NQ) or saline (NS). NQ produces dopamine D2 receptor supersensitivity that persists throughout the animal's lifetime, and therefore has relevance towards schizophrenia. In two experiments, rats were ip administered quinpirole (1mg/kg) or saline from postnatal day (P)1-21. After an initial preference test at P42-43, animals were conditioned for eight consecutive days with saline or nicotine (0.6mg/kg free base) in Experiment 1 or saline or nicotine (1.8mg/kg free base) in Experiment 2. In addition, there were NQ and NS groups in each experiment given the antipsychotic haloperidol (0.05mg/kg) or clozapine (2.5mg/kg) before nicotine conditioning. A drug free post-conditioning test was administered at P52. At P53, the nucleus accumbens (NAc) was analyzed for glial cell-line derived neurotrophic factor (GDNF). Results revealed that NQ enhanced nicotine CPP, but blunted the aversive properties of nicotine. Haloperidol was more effective than clozapine at blocking nicotine CPP in Experiment 1, but neither antipsychotic affected nicotine conditioned place aversion in Experiment 2. NQ increased accumbal GDNF which was sensitized in NQ rats conditioned to nicotine in Experiment 1, but the aversive dose of nicotine reduced GDNF in NQ animals in Experiment 2. Both antipsychotics in combination with the aversive dose of nicotine decreased accumbal GDNF. In sum, increased D2 receptor sensitivity influenced the associative properties and GDNF response to nicotine which has implications towards pharmacological targets for smoking cessation in schizophrenia.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescence; Antipsychotics; Conditioned place preference; Dopamine D2 receptor; Nicotine; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28314679      PMCID: PMC5599315          DOI: 10.1016/j.schres.2017.03.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  55 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

2.  Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats.

Authors:  J U Adams; J M Careri; T R Efferen; J Rotrosen
Journal:  Behav Pharmacol       Date:  2001-12       Impact factor: 2.293

3.  Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.

Authors:  Catarina A R V Gomes; Sandra H Vaz; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Brain Res       Date:  2006-08-28       Impact factor: 3.252

4.  A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra.

Authors:  H A Boger; L D Middaugh; P Huang; V Zaman; A C Smith; B J Hoffer; A C Tomac; A-Ch Granholm
Journal:  Exp Neurol       Date:  2006-08-02       Impact factor: 5.330

5.  Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.

Authors:  Nii Addy; Edward D Levin
Journal:  Neuropsychopharmacology       Date:  2002-10       Impact factor: 7.853

6.  Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.

Authors:  Brandon J Hall; Susan Slade; Cheyenne Allenby; Munir G Kutlu; Edward D Levin
Journal:  Neuropharmacology       Date:  2015-03-19       Impact factor: 5.250

7.  Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.

Authors:  Brianna Sheppard; Julia Lehmann; Zackary A Cope; Russell W Brown
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

8.  Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.

Authors:  S Kobayashi; S O Ogren; B J Hoffer; L Olson
Journal:  Exp Neurol       Date:  1998-12       Impact factor: 5.330

9.  Clozapine attenuates cocaine conditioned place preference.

Authors:  T A Kosten; E J Nestler
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

10.  Nicotine-induced conditioned place preference in adolescent and adult rats.

Authors:  Bonnie J Vastola; Lewis A Douglas; Elena I Varlinskaya; Linda P Spear
Journal:  Physiol Behav       Date:  2002-09
View more
  4 in total

Review 1.  Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.

Authors:  Richard M Kostrzewa; Karolina Wydra; Malgorzata Filip; Cynthia A Crawford; Sanders A McDougall; Russell W Brown; Dasiel O Borroto-Escuela; Kjell Fuxe; Raul R Gainetdinov
Journal:  J Pharmacol Exp Ther       Date:  2018-06-19       Impact factor: 4.030

Review 2.  Opposite regulation of conditioned place preference and intravenous drug self-administration in rodent models: Motivational and non-motivational examples.

Authors:  Thomas A Green; Michael T Bardo
Journal:  Neurosci Biobehav Rev       Date:  2020-06-12       Impact factor: 8.989

3.  Effects of an adenosine A2A agonist on the rewarding associative properties of nicotine and neural plasticity in a rodent model of schizophrenia.

Authors:  Wesley Drew Gill; Heath W Shelton; Katherine C Burgess; Russell W Brown
Journal:  J Psychopharmacol       Date:  2019-11-07       Impact factor: 4.562

4.  Behavioral outputs of negative symptom domains of schizophrenia.

Authors:  Octavia Căpățînă; Mihaela Fadgyas Stănculete; Ioana Micluția
Journal:  Exp Ther Med       Date:  2021-05-26       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.